Year: 2019
AB Šiaulių bankas, įmonės kodas 112025254, buveinės adresas: Tilžės g. 149, Šiauliai, Lietuva.AB Šiaulių bankas valdybos sprendimu 2019 m. gruodžio 21 d. pirma laiko išpirko 20 milijonų eurų obligacijų emisiją (ISIN kodas LT0000432015), t.y., įvykdė emisijos sąlygose numatytą pirkimo pasirinkimo sandorį (call option).Išpirktos visos emisijos obligacijos, sumokant investuotojams obligacijų nominalią vertę ir sukauptas neišmokėtas palūkanas. Papildomą informaciją teikiaRinkų ir iždo departamento direktoriusTomas Varenbergas +370 5203 2200, tomas.varenbergas@sb.lt
FPSO Liza Destiny producing and on hire
Written by Customer Service on . Posted in Public Companies.
December 23, 2019SBM Offshore is pleased to announce that FPSO Liza Destiny has produced first oil as of December 20, 2019 and is formally on hire.The FPSO is installed at the Liza field, which is located circa 200 kilometers offshore Guyana in the Stabroek block. ExxonMobil affiliate Esso Exploration and Production Guyana Limited is operator and holds 45 percent interest in the Stabroek Block. Hess Guyana Exploration Ltd. holds 30 percent interest and CNOOC Petroleum Guyana Limited, a wholly-owned subsidiary of CNOOC Limited, holds 25 percent interest.Bruno Chabas, CEO of SBM Offshore, commented:“We are proud of FPSO Liza Destiny reaching first oil for our client and the people of Guyana. The vessel is producing the first oil in Guyana’s history. Our teams have done an excellent job by completing the project well in...
WISeKey to Hold its 13th Annual Cybersecurity IoT Bloackchain Roundtable in Davos on January 22, 2020
Written by Customer Service on . Posted in Public Companies.
WISeKey to Hold its 13th Annual Cybersecurity IoT Bloackchain Roundtable in Davos on January 22, 2020Geneva – December 23, 2019 – WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, today announces that it will hold its 13th Annual Cybersecurity Roundtable in Davos on January 22, 2020 (starting at 6:00pm CET), at the Piano Bar of Hotel Europe (Promenade 63, 7270, Davos Platz, Switzerland).This closed-door event will take place during the upcoming World Economic Forum annual meeting in Davos. For more information and registration details visit https://www.wisekey.com/davos/.Agenda for the 2020 Cybersecurity Roundtable includes the following events:Cybersecurity Tech Accord (networking reception and panel discussion)2020 Blockchain Outstanding...
Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
Written by Customer Service on . Posted in Public Companies.
– Roche obtains the exclusive right to launch and commercialize SRP-9001 outside the United States –– At closing, Sarepta will receive an upfront payment of $1.15 billion, comprising $750 million in cash and $400 million in Sarepta stock, priced at $158.59 per share of common stock – – Additionally, Sarepta is eligible to receive up to $1.7 billion in regulatory and sales milestones, plus royalties on net sales –– Sarepta will continue to be responsible for clinical development and manufacturing of SRP-9001 with global clinical development costs shared equally with Roche –– Sarepta will host a conference call on Monday, Dec. 23 at 08:30 a.m. ET –CAMBRIDGE, Mass., Dec. 23, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic...
Sanofi commences tender offer for acquisition of Synthorx, Inc.
Written by Customer Service on . Posted in Public Companies.
AttachmentPress Release
Sanofi lance l’offre publique d’achat en vue de l’acquisition de Synthorx, Inc.
Written by Customer Service on . Posted in Public Companies.
Pièce jointeCommuniqué de presse
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Written by Customer Service on . Posted in Public Companies.
Roche obtains the exclusive right to launch and commercialize SRP-9001, Sarepta’s investigational micro-dystrophin gene therapy for Duchenne muscular dystrophy (DMD) outside the United StatesAt closing, Roche will pay an upfront of $750million in cash and $400million worth in equitySarepta is eligible to receive up to $1.7billion in regulatory and sales milestones, plus royalties on net salesSarepta will continue to be responsible for clinical development and manufacturing of SRP-9001 with global clinical development costs shared equally with RocheBasel, 23 December 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT), today announced the signing of a licensing agreement providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), Sarepta’s investigational...
Hoivatilat Plc: Schedules for financial reports in 2020
Written by Customer Service on . Posted in Public Companies.
Hoivatilat PlcStock Exchange Release, 23 December 2019, at 8 a.m. (EET)Hoivatilat Plc: Schedules for financial reports in 2020Hoivatilat Plc will publish the following financial reports in 2020:25 February 2020: Financial Statements Bulletin for 20196 May 2020: Business Review, January-March 202019 August 2020: Half-Year Review, January-June 20204 November 2020: Business Review, January-September 2020The Annual General Meeting will be held on 25 March 2020. The company’s Board of Directors will issue a separate notice of the Annual General Meeting later.The Annual Report for 2019 will be published in week 10 of 2020.Hoivatilat PlcBoard of DirectorsFurther information:Hoivatilat in brief:Hoivatilat Plc specialises in producing, developing, owning and leasing out nursing homes, day care centres, schools and service communities....
Hoivatilat Oyj: Vuoden 2020 taloudellisten katsausten aikataulut
Written by Customer Service on . Posted in Public Companies.
Hoivatilat OyjPörssitiedote 23.12.2019 kello 8:00 EETHoivatilat Oyj: Vuoden 2020 taloudellisten katsausten aikataulutHoivatilat Oyj julkistaa seuraavat taloudelliset katsaukset vuonna 2020:25.2.2020 Tilinpäätöstiedote vuodelta 20196.5.2020 Liiketoimintakatsaus tammi-maaliskuu 202019.8.2020 Puolivuosikatsaus tammi-kesäkuu 20204.11.2020 Liiketoimintakatsaus tammi-syyskuu 2020Varsinainen yhtiökokous 2020 pidetään 25.3.2020. Yhtiön hallitus esittää erillisen yhtiökokouskutsun myöhemmin.Vuoden 2019 vuosikertomus julkaistaan viikolla 10, 2020.Hoivatilat OyjHallitusLisätietoja:Hoivatilat lyhyesti:Hoivatilat Oyj on erikoistunut päivä- ja hoivakotikiinteistöjen sekä palvelukortteleiden ja koulujen tuottamiseen, omistamiseen ja vuokraamiseen. Hoivatilat on...
Italeaf: TerniEnergia signed the closing for the sale of 4 photovoltaic plants for a total price of Euro 4.1 million
Written by Customer Service on . Posted in Mergers And Acquisitions.
PRESS RELEASE 23 DECEMBER 2019Italeaf: TerniEnergia signed the closing for the sale of 4 photovoltaic plants for a total price of Euro 4.1 millionThe sale of the third tranche of a total perimeter of 22 photovoltaic plants to Mareccio Energia S.r.l., a platform for the aggregation of assets in Italy of a primary investment fund, in partnership with the sponsor LCF Alliance, through the vehicle company Italia T1 Roncolo, has been completed.Total capacity of the plants subject to closing equal to 4 MWNet collection of the third tranche for TerniEnergia of approximately Euro 3.6 million (net of the Escrow account, equal to Euro 0.5 million)Total value of the transaction (Enterprise Value) of approximately Euro 10.6 millionPart of the purchase price, equal to Euro 0.5 million, will be deposited into an Escrow account as a guarantee of Seller’s...
